BluePoint Lab Injectables

PEMETREXED DISODIUM

Manufacturer:

BluePoint Lab Injectables

Pemetrexed Disodium HCPCS:

J9322

HCPCS Code Descriptor:

Injection, pemetrexed (bluepoint) not therapeutically equivalent to j9305, 10 mg

Category:

J Code

Pemetrexed Disodium NDCs:

No actively aligned NDCs found

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Intravenous

Pemetrexed Disodium CPT Codes:

Potential CPT administration codes for Pemetrexed Disodium can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Pemetrexed Disodium:

PEMETREXED DISODIUM is a Oncology drug manufactured by BluePoint Lab Injectables and administered via the Intravenous route of administration. The J Code: J9322 is aligned to the drug PEMETREXED DISODIUM.

ACCESS PRICING AND MORE BY REGISTERING

J9322 Added Date:

July 1, 2023

J9322 Effective Date:

July 1, 2023

J9322 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Pemetrexed Disodium billing and coding information.
Our team did not identify a source for Pemetrexed Disodium patient assistance information. Please reach out to our team if you feel that this is a mistake.
PEMETREXED DISODIUM prescribing information can be found at the link below:
Information regarding PEMETREXED DISODIUM’s side effects can be found at MedlinePlus